title: [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
authors.affiliation: EFS Nord de France, Site de Lille, 21, rue C. Guérin, 59012 Lille Cedex.
authors.forename: L
authors.initials: L
authors.lastname: Mannessier
authors.forename: S
authors.initials: S
authors.lastname: Alie-Daram
authors.forename: F
authors.initials: F
authors.lastname: Roubinet
authors.forename: A S
authors.initials: AS
authors.lastname: Valat
authors.forename: M H
authors.initials: MH
authors.lastname: Depoortère
authors.forename: A
authors.initials: A
authors.lastname: Fournié
authors.forename: F
authors.initials: F
authors.lastname: Puech
mesh_terms: D001788:Blood Grouping and Crossmatching; D004899:Erythroblastosis, Fetal / Q000209:etiology / Q000517:prevention & control*; D005260:Female; D005331:Fetomaternal Transfusion / Q000150:complications; D006801:Humans; D007231:Infant, Newborn; D049590:Postpartum Period; D011247:Pregnancy; D012203:Rh Isoimmunization / Q000150:complications / Q000517:prevention & control; D018029:Rho(D) Immune Globulin / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D018029:Rho(D) Immune Globulin